Comments
Loading...
Adverum Biotechnologies Insider Trading Activity | NASDAQ:ADVM | Benzinga
Track the latest Adverum Biotechnologies insider trading activity. Stay informed on recent buys, sells, and market impact for Adverum Biotechnologies stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Adverum Biotechnologies Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On April 24, 2025, Braden Michael Leonard, the company's - purchased 350K shares for $3 each.
- On April 28, 2025, Braden Michael Leonard, the company's - purchased 37K shares for $5.11 each.
- On April 2, 2025, Braden Michael Leonard, the company's - purchased 34.78K shares for $4.23 each.
Ownership Statistics for Adverum Biotechnologies Inc
Shares Outstanding
20.891M
Insider Shares Owned
5.517M
Insider Percentage Owned
26.4%
Institutional Shares Held
3.899M
Institutional Percentage Held
18.7%
| May 16, 2025 | Peter Soparkar | CHIEF OPERATING OFFICER | -2.96K | $2.00 | -$5.92K | SELL | -7.03% | 39.15K | May 15 | View |
| May 16, 2025 | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | -924.00 | $2.00 | -$1.85K | SELL | -6.29% | 13.77K | May 15 | View |
| May 16, 2025 | Laurent Fischer | CEO, PRESIDENT AND DIRECTOR | -9.13K | $2.00 | -$18.25K | SELL | -9.45% | 87.49K | May 15 | View |
| Apr 28, 2025 | Braden Michael Leonard | — | 37.00K | $5.11 | $188.93K | BUY | 1.31% | 2.86M | Mar 26 - Mar 27 | View |
| Apr 24, 2025 | Braden Michael Leonard | — | 350.00K | $3.00 | $1.05M | BUY | ∞ | 191.80K | Apr 22 - Apr 23 | View |
| Apr 02, 2025 | Braden Michael Leonard | — | 34.77K | $4.23 | $147.08K | BUY | 1.21% | 2.90M | Mar 31 - Apr 02 | View |
| Mar 27, 2025 | Braden Michael Leonard | — | 3.81K | $5.11 | $16.75K | BUY | 0.13% | 2.86M | Mar 26 - Mar 27 | View |
| Mar 20, 2025 | Braden Michael Leonard | — | 117.94K | $4.98 | $587.57K | BUY | 4.35% | 2.83M | Mar 18 - Mar 20 | View |
| Feb 28, 2025 | Braden Michael Leonard | — | 336.76K | $4.27 | $1.44M | BUY | 14.19% | 2.71M | Feb 26 - Feb 28 | View |
| Jul 31, 2024 | Braden Michael Leonard | — | 85.80K | $7.15 | $613.47K | BUY | 3.75% | 2.37M | Jul 30 | View |
| Jul 18, 2024 | Braden Michael Leonard | — | 216.26K | $8.26 | $1.79M | BUY | 10.44% | 2.29M | Jul 17 - Jul 18 | View |
| Feb 09, 2024 | Paul James Scopa | — | 100.00K | $1.35 | $135.00K | BUY | 2999.40% | 103.33K | Feb 07 | View |
| Feb 09, 2024 | Mark Lupher Jr | — | 130.00K | $1.35 | $175.50K | BUY | ∞ | 130.00K | Feb 07 | View |
| Sep 18, 2023 | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | -6.20K | $1.52 | -$9.43K | SELL | -11.51% | 47.67K | Sep 15 | View |
| Jun 09, 2023 | Linda Rubinstein | CHIEF FINANCIAL OFFICER | 100.00K | $1.45 | $145.49K | BUY | ∞ | 100.00K | Jun 07 | View |
| Mar 17, 2023 | Brigit Riley | CHIEF SCIENTIFIC OFFICER | -7.30K | $0.78 | -$5.70K | SELL | -5.85% | 117.44K | Mar 15 | View |
| Mar 17, 2023 | Peter Soparkar | CHIEF OPERATING OFFICER | -13.36K | $0.78 | -$10.44K | SELL | -4.78% | 265.89K | Mar 15 | View |
| Mar 17, 2023 | Laurent Fischer | CEO, PRESIDENT AND DIRECTOR | -41.24K | $0.78 | -$32.23K | SELL | -5.62% | 692.14K | Mar 15 | View |
| Sep 21, 2022 | Richard Beckman | CHIEF MEDICAL OFFICER | -4.27K | $1.07 | -$4.57K | SELL | -9.86% | 39.06K | Sep 19 | View |
| Sep 21, 2022 | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | -6.06K | $1.07 | -$6.48K | SELL | -11.23% | 47.88K | Sep 19 | View |
| Sep 21, 2022 | Peter Soparkar | SEE REMARKS SECTION | -13.30K | $1.07 | -$14.23K | SELL | -4.64% | 273.25K | Sep 19 | View |
| Sep 21, 2022 | Brigit Riley | CHIEF SCIENTIFIC OFFICER | -7.27K | $1.07 | -$7.77K | SELL | -5.77% | 118.73K | Sep 19 | View |
| Sep 21, 2022 | Laurent Fischer | CEO, PRESIDENT AND DIRECTOR | -41.08K | $1.07 | -$43.94K | SELL | -5.35% | 727.38K | Sep 19 | View |
| May 24, 2022 | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | 20.00K | $0.84 | $16.80K | BUY | 3333.33% | 20.60K | May 23 | View |
| May 19, 2022 | Richard Beckman | CHIEF MEDICAL OFFICER | 10.00K | $0.82 | $8.23K | BUY | ∞ | 10.00K | May 17 | View |
| May 18, 2022 | Dawn Svoronos | DIRECTOR | 30.00K | $0.85 | $25.58K | BUY | 150.00% | 50.00K | May 16 | View |
| May 17, 2022 | Rupert D'Souza | CHIEF FINANCIAL OFFICER | 20.00K | $0.84 | $16.86K | BUY | 2352.94% | 20.85K | May 13 - May 17 | View |
| Apr 22, 2022 | Laurent Fischer | CEO, PRESIDENT AND DIRECTOR | 25.00K | $1.11 | $27.80K | BUY | 3.39% | 762.46K | Apr 20 | View |
| Apr 20, 2022 | Peter Soparkar | SEE REMARKS SECTION | 21.93K | $1.14 | $24.99K | BUY | 8.48% | 280.56K | Apr 19 | View |
| Dec 10, 2021 | Laurent Fischer | CEO, PRESIDENT AND DIRECTOR | 25.00K | $1.82 | $45.61K | BUY | 3.51% | 737.46K | Dec 08 - Dec 09 | View |
| Dec 10, 2021 | Peter Soparkar | SEE REMARKS SECTION | 25.00K | $1.91 | $47.75K | BUY | 10.70% | 258.63K | Dec 08 | View |
| Nov 17, 2021 | James Paul Scopa | DIRECTOR | -50.00K | $2.18 | -$109.00K | SELL | -93.75% | 3.33K | Nov 15 | View |
| Oct 04, 2021 | Julie Clark | CHIEF MEDICAL OFFICER | -4.77K | $2.17 | -$10.34K | SELL | -2.81% | 164.72K | Sep 30 | View |
| Apr 01, 2021 | Dawn Svoronos | DIRECTOR | 20.00K | $10.02 | $200.34K | BUY | ∞ | 20.00K | Mar 31 | View |
| Mar 24, 2021 | Laurent Fischer | CEO AND DIRECTOR | 10.00K | $9.88 | $98.78K | BUY | 61.38% | 26.29K | Mar 24 | View |
| Mar 24, 2021 | Patrick Machado | DIRECTOR | 10.00K | $9.92 | $99.20K | BUY | 12.79% | 88.18K | Mar 24 | View |
| Feb 11, 2021 | Leone Patterson | PRESIDENT AND CFO | -12.53K | $14.10 | -$176.72K | SELL | -11.34% | 97.95K | Feb 09 | View |
| Jan 19, 2021 | Patrick Machado | DIRECTOR | 10.00K | $11.52 | $115.17K | BUY | 14.67% | 78.18K | Jan 15 | View |
| Jan 19, 2021 | Laurent Fischer | CEO AND DIRECTOR | 8.60K | $11.53 | $99.19K | BUY | 111.80% | 16.29K | Jan 15 | View |
| Aug 19, 2020 | Peter Soparkar | — | 7.69K | $13.00 | $100.00K | PURCHASE | 256.40% | 10.69K | Aug 17 | View |
| Aug 19, 2020 | Laurent Fischer | — | 7.69K | $13.00 | $100.00K | PURCHASE | ∞ | 7.69K | Aug 17 | View |
| Jul 22, 2020 | Mehdi Gasmi | — | 0.00 | $11.20 | -$63.98K | OPTION EXERCISE | 0.00% | 274.44K | Jul 20 | View |
| Jun 23, 2020 | Mehdi Gasmi | — | 0.00 | $14.93 | -$478.31K | OPTION EXERCISE | 0.00% | 274.44K | Jun 22 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
